Best Hospitals for Alpha-1-Antitrypsin Deficiency in India
90 liver transplant & hpb hospitals in our India network are listed, across 5 cities (Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai), accredited by JCI, NABH, ISO, NABL, with 51,822 beds combined.
This page lists the liver transplant & hpb hospitals in our directory offering Alpha-1-Antitrypsin Deficiency in India, including Nanavati Super Specialty Hospital, Apollo Hospitals, Medanta - The Medicity, Artemis Hospital and others. Hospitals are listed across Mumbai, Delhi NCR, Bengaluru, Hyderabad, Chennai. Each listing links through to the hospital's full profile page.
Ask us about alpha-1-antitrypsin deficiency in India
Share a few details and our care coordination team will get back to you with next steps.
Top Hospitals for Alpha-1-Antitrypsin Deficiency in India
🇮🇳 Nanavati Super Specialty Hospital
Patients considering alpha-1-antitrypsin deficiency can be cared for by Nanavati Super Specialty Hospital's care team in Mumbai, India, from initial consultation through recovery. Nanavati Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.
🇮🇳 Apollo Hospitals
Patients considering alpha-1-antitrypsin deficiency can be cared for by Apollo Hospitals's care team in New Delhi, India, from initial consultation through recovery. Apollo Hospitals, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.
🇮🇳 Medanta - The Medicity
Patients considering alpha-1-antitrypsin deficiency can be cared for by Medanta - The Medicity's care team in Gurgaon, India, from initial consultation through recovery. Medanta - The Medicity, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.
🇮🇳 Artemis Hospital
Patients considering alpha-1-antitrypsin deficiency can be cared for by Artemis Hospital's care team in Gurgaon, India, from initial consultation through recovery. Artemis Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.
🇮🇳 Fortis Memorial Research Institute
Patients considering alpha-1-antitrypsin deficiency can be cared for by Fortis Memorial Research Institute's care team in Gurgaon, India, from initial consultation through recovery. Fortis Memorial Research Institute, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.
🇮🇳 Kokilaben Dhirubhai Ambani Hospital
Patients considering alpha-1-antitrypsin deficiency can be cared for by Kokilaben Dhirubhai Ambani Hospital's care team in Mumbai, India, from initial consultation through recovery. Kokilaben Dhirubhai Ambani Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.
🇮🇳 Tata Memorial Hospital
Patients considering alpha-1-antitrypsin deficiency can be cared for by Tata Memorial Hospital's care team in Mumbai, India, from initial consultation through recovery. Tata Memorial Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.
🇮🇳 Max Super Specialty Hospital
Patients considering alpha-1-antitrypsin deficiency can be cared for by Max Super Specialty Hospital's care team in New Delhi, India, from initial consultation through recovery. Max Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.
🇮🇳 Narayana Health
Patients considering alpha-1-antitrypsin deficiency can be cared for by Narayana Health's care team in Bengaluru, India, from initial consultation through recovery. Narayana Health, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.
🇮🇳 Yashoda Hospitals, Hi-Tech City
Patients considering alpha-1-antitrypsin deficiency can be cared for by Yashoda Hospitals, Hi-Tech City's care team in Hi-Tech City, Hyderabad, India, from initial consultation through recovery. Yashoda Hospitals, Hi-Tech City, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing alpha-1-antitrypsin deficiency.
Top Liver Transplant & HPB Doctors in India
FeaturedDr. Abhideep Chaudhary
- 22+ years of experience in HPB & Liver Transplant Surgeon
- Chairman & HOD — HPB Surgery & Liver Transplantation, BLK-Max Super Speciality Hospital, New Delhi
- Associate Director & Head — Surgical Gastroenterology and Liver Transplantation, Jaypee Hospital, Noida
- Living Donor Liver Transplant (LDLT)
- Deceased Donor Liver Transplant (DDLT)
- Robotic Donor Hepatectomy
- Paediatric Liver Transplant
- ABO-Incompatible Liver Transplant

Dr. Giriraj Bora
- 20+ years of experience in Liver Transplant & HPB Surgeon
- Chief — Liver Transplant; Sr. Consultant — GI & HPB Surgery, Artemis Hospital, Gurugram
- Consultant — Liver Transplant, Centre for Liver and Biliary Sciences (CLBS), New Delhi
- Living Donor Liver Transplant (LDLT)
- Deceased Donor Liver Transplant (DDLT)
- ABO-Incompatible Liver Transplant
- Combined Liver-Kidney Transplantation
- Whipple Procedure (Pancreaticoduodenectomy) with Portal Vein Reconstruction
Dr. Arvinder Singh Soin
- 36+ years of experience in Liver Transplant & HPB Surgeon
- Chairman — Liver Transplant, Medanta – The Medicity, Gurugram
- Founder and Head — Liver Transplant Programme, Indraprastha Apollo Hospitals, New Delhi
- Living donor liver transplantation (LDLT)
- Deceased donor liver transplantation (DDLT)
- ABO-incompatible liver transplantation
- Split liver transplantation
- Paediatric liver transplantation

Dr. Ameet Mandot
- 24+ years of experience in Hepatologist & Liver Transplant Specialist
- Director & Clinical Lead — Adult Hepatology & Liver Transplant, Gleneagles Hospital, Mumbai — Present
- Academic Head, Department of Gastroenterology, Bombay Hospital, Mumbai
- Liver Transplantation (Orthotopic and Living Donor)
- Endoscopic Retrograde Cholangiopancreatography (ERCP)
- Endoscopic Variceal Ligation and Sclerotherapy
- Transjugular Intrahepatic Portosystemic Shunt (TIPS)
- Ascitic Tap and Management of Refractory Ascites

Dr. Amit Chopde
- 12+ years of experience in Hepatobiliary & Pancreatic Surgeon
- Consultant, Surgical Gastroenterology — Gleneagles Hospital, Mumbai, Present
- Assistant Professor and Consultant, Department of HPB & GI Oncology — Tata Memorial Hospital, Mumbai
- Liver transplant evaluation and management
- Hepatic resection for cancer and benign tumors
- Whipple procedure (pancreaticoduodenectomy)
- Distal and total pancreatectomy
- Robotic hepatobiliary and pancreatic surgery

Dr. Amit Jha
- 16+ years of experience in Liver Transplant Anaesthesiologist
- Senior Consultant & Head – Liver Transplant & GI Surgery Anaesthesia, Paras Hospitals, Gurugram
- Specialist in Transplant Anaesthesia – Liver Transplant & HPB Surgery unit, Paras Hospitals, Gurugram
- Liver transplant anaesthesia and perioperative management
- Deceased donor liver transplant
- Living donor liver transplant
- Pediatric liver transplant
- Liver retransplantation
How we selected these hospitals
A hospital appears on this page when Liver Transplant & HPB is among its listed specialties and it is located in India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Alpha-1-Antitrypsin Deficiency in India?
Choosing the right hospital for alpha-1-antitrypsin deficiency is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include liver transplant & hpb rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Alpha-1-Antitrypsin Deficiency
Alpha-1-Antitrypsin Deficiency (AATD) is a serious inherited metabolic disorder that leads to progressive emphysema and liver disease; AAT augmentation therapy (intravenous infusion of purified human alpha-1-antitrypsin) is the only disease-modifying treatment proven to slow lung function decline in Pi*ZZ and related phenotypes, with clinical studies demonstrating a statistically significant reduction in CT-measured lung density loss and annual FEV1 decline.
Clinical Overview
- Alpha-1-Antitrypsin Deficiency (AATD) is an autosomal co-dominant genetic disorder caused by mutations in the SERPINA1 gene, most commonly the Pi*Z (Glu342Lys) allele.
- The resulting misfolded AAT protein is retained within hepatic endoplasmic reticulum, reducing circulating AAT to less than 11 µmol/L — far below the protective threshold of 35 µmol/L needed to neutralise neutrophil elastase in alveolar tissue.
- The unopposed elastase activity progressively destroys alveolar walls, producing panlobular emphysema with a characteristic basal predominance on high-resolution CT (HRCT).
Who is a Candidate?
- CONFIRMED PHENOTYPE: Pi*ZZ, Pi*ZNull, Pi*SZ, or other severe AATD genotypes confirmed by serum AAT level (< 11 µmol/L or < 57 mg/dL by nephelometry) AND SERPINA1 genotyping or isoelectric focusing (IEF)
- PULMONARY ELIGIBILITY FOR AUGMENTATION: FEV1 15–65% predicted on spirometry; CT-documented emphysema (quantitative PD15 densitometry); non-smoker or smoking cessation confirmed ≥ 6 months; absence of IgA deficiency (risk of anaphylaxis to plasma products)
- LIVER DISEASE EVALUATION: All AATD patients require baseline liver assessment — serum LFTs, FibroScan® (liver stiffness ≥ 7 kPa warrants enhanced surveillance), abdominal ultrasound, and AFP for HCC screening in cirrhotic patients
- REQUIRED PRE-TREATMENT DIAGNOSTICS: Full pulmonary function tests (spirometry, body plethysmography, DLCO); HRCT thorax with quantitative densitometry; 6-minute walk test (6MWT) and SGRQ-C quality-of-life score; echocardiography (ECHO) to exclude pulmonary hypertension (RVSP > 40 mmHg modifies transplant candidacy); complete blood count, coagulation profile, serum protein electrophoresis; hepatitis B/C serology and HIV screening
- +4 more
Treatment Options & Approaches
- STANDARD AAT AUGMENTATION THERAPY (INTRAVENOUS): Weekly IV infusion of purified, pasteurised, human plasma-derived alpha-1-antitrypsin concentrate at 60 mg/kg body weight, administered over 15–30 minutes in an outpatient or day-care setting.
- This is the only FDA-approved, EMA-approved disease-modifying therapy for AATD-related emphysema.
- The RAPID and RAPID-OLE trials (the only double-blind, placebo-controlled studies in AATD) demonstrated a 34% reduction in annual CT lung density loss (PD15 endpoint) and a significant benefit in FEV1 decline in the treatment arm over 4 years.
Recovery
- PHASE 1 — PRE-ARRIVAL PREPARATION (2–4 weeks before travel):
Risks to be aware of
- AAT augmentation therapy has an established safety profile across three decades of clinical use, but patients and clinicians must consider the following specific risks and limitations:
Why GAF Healthcare
- GAF Healthcare provides a fully integrated non-medical support infrastructure designed to eliminate barriers to international treatment access for AATD patients:
Common questions about Alpha-1-Antitrypsin Deficiency
What is the cost of Alpha-1-Antitrypsin Deficiency Treatment (AAT Augmentation Therapy) in India versus the UAE?
How long do I need to stay in India or the UAE before I am fit to fly home after starting AAT Augmentation Therapy?
What is the success rate of AAT Augmentation Therapy and related AATD treatments?
Related pages
How GAF Healthcare Assists in Choosing the Best Hospital for Alpha-1-Antitrypsin Deficiency in India
Discover the Top Hospitals for Alpha-1-Antitrypsin Deficiency in India
This page lists 90 accredited liver transplant & hpb hospitals in India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Patient Success Story
Frequently asked questions about alpha-1-antitrypsin deficiency in India
How many liver transplant & hpb hospitals are listed in India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Which cities in India have liver transplant & hpb hospitals listed?
Are these hospitals internationally accredited?
Can I get a treatment plan and cost estimate before I travel?
Do you help with visa, travel and accommodation?
What support do I get during and after treatment?
What does the "Featured" label next to a hospital's name mean?
How do I get matched with the right hospital for alpha-1-antitrypsin deficiency?
Does the listed cost cover everything?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for alpha-1-antitrypsin deficiency in India.
Contact us to report an inaccuracy on this page.
